Disease Progression Clinical Trial
— WARD-HOMEOfficial title:
Continuous and Wireless Vital Sign Monitoring in Patients at Home After Acute Medical Admission
Verified date | September 2023 |
Source | Bispebjerg Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The current study aims to investigate the feasibility of transmitting continuous and wireless vital sign data in real time from patients home to the hospital in patients discharged after an acute medical hospitalization
Status | Completed |
Enrollment | 30 |
Est. completion date | July 30, 2023 |
Est. primary completion date | July 30, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adult patients (=18 years) Admitted with an acute medical disease and scheduled for discharge to their own homes within five days from inclusion. Exclusion Criteria: - Allergy to plaster, plastic, or silicone. - A pacemaker or Implantable Cardioverter Defibrillator (ICD) device. - If the patient was deemed not able to open the front door when visited by the investigator. - Inability to give informed consent. |
Country | Name | City | State |
---|---|---|---|
Denmark | Bispebjerg Hospital | Copenhagen | NV |
Lead Sponsor | Collaborator |
---|---|
Bispebjerg Hospital | Rigshospitalet, Denmark, Technical University of Denmark |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Re-admission and cause of re-admission within 30-days | 30-days follow up | ||
Other | User experiences (patient and personnel) | Within 72 hours of monitoring | ||
Primary | Duration of data collection from the Lifetouch patch | Up to 72 hours of monitoring | ||
Secondary | Duration of complete peripheral saturation data | Up to 72 hours of monitoring | ||
Secondary | Duration of complete blood pressure data | Up to 72 hours of monitoring | ||
Secondary | Cummulated duration of desaturation | Peripheral saturation below 88% and 85% | Up to 72 hours of monitoring | |
Secondary | Number of events with SpO2 < 88% in at least 10 consecutive minutes | Up to 72 hours of monitoring | ||
Secondary | Number of events with SpO2 < 85% in at least 5 consecutive minutes | Up to 72 hours of monitoring | ||
Secondary | Number of deviating vital parameters in accordance to defined microevents | Up to 72 hours of monitoring |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03474692 -
Virta Health Registry
|
||
Recruiting |
NCT05022147 -
Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease
|
Phase 1 | |
Not yet recruiting |
NCT04115787 -
Conservative Management in Patients Diagnosed With Grade 2 or Grade 3 CIN
|
||
Completed |
NCT01507415 -
Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD?
|
N/A | |
Completed |
NCT04776837 -
Predicting Disease Progression and/or Recurrence in Cancer
|
||
Active, not recruiting |
NCT05085275 -
Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease
|
Phase 3 | |
Completed |
NCT01947127 -
Venous Lactate in Progression to Overt Septic Shock and Mortality in Non-elderly Sepsis Patients in Emergency Department
|
N/A | |
Completed |
NCT01923103 -
Natural Disease Progress of Dupuytren Disease
|
||
Active, not recruiting |
NCT02011932 -
Prospective Observational Study of Disease Progression in Chronic Hepatitis C
|
N/A | |
Not yet recruiting |
NCT05851209 -
Biomarkers and Mechanisms of Disease Progression and Outcome of Aortic Stenosis in Humans
|
||
Withdrawn |
NCT02134652 -
Ability of Bedside Ultrasound to Predict Progression of Severity of Disease in Dengue Fever
|
N/A | |
Recruiting |
NCT02753192 -
Dysarthria in Parkinson's Disease: Lusophony vs. Francophony Comparison
|
N/A | |
Terminated |
NCT00338091 -
Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency
|
N/A | |
Completed |
NCT04343456 -
Salvage Surgery for Patients With Metastatic GIST With Rego
|
||
Completed |
NCT03174912 -
In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both?
|
Phase 4 | |
Completed |
NCT01425073 -
Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya
|
N/A | |
Terminated |
NCT04436120 -
Treatment Resistance Following Anti-cancer Therapies
|
N/A | |
Terminated |
NCT02681809 -
A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR
|
Phase 2 | |
Completed |
NCT02499068 -
Madrid Project on the Management of Chronic Obstructive Pulmonary Disease With Home Telemonitoring
|
N/A | |
Completed |
NCT00567983 -
Topical Cyclosporine and Disease Progression
|
Phase 4 |